Role of protein kinase C in angiotensin II-induced renal vasoconstriction in genetically hypertensive rats

American Journal of Physiology

Volumn 270, Issue 6 PART 2, 1996, Pages

  Ruan, Xiaoping ^a   Arendshorst, William J ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

AT1 receptor subtype; phospholipase C; Kidney; Losartan; Renal circulation; Spontaneously hypertensive rat; Vascular reactivity; Vascular smooth muscle

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; CHELERYTHRINE; CYCLIC AMP; INDOMETACIN; LOSARTAN; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; STAUROSPORINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENZYME ACTIVATION; KIDNEY BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE; VASOCONSTRICTION;

ALKALOIDS; ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; BENZOPHENANTHRIDINES; BIPHENYL COMPOUNDS; HEMODYNAMIC PROCESSES; HYPERTENSION; IMIDAZOLES; LOSARTAN; PHENANTHRIDINES; PROTEIN KINASE C; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, ANGIOTENSIN; RENAL CIRCULATION; STAUROSPORINE; TETRAZOLES; VASOCONSTRICTOR AGENTS;

EID: 0029797845     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajprenal.1996.270.6.f945     Document Type: Article

References (35)

1. Andrea, J. E., and M. P. Walsh. Protein kinase C of smooth muscle. Hypertension Dallas 20::585-595, 1992.
2. Barnett, R. L., L. Ruffini, L. Ramsammy, R. Pasmantier, M. M. Friedlander, and E. P. Nord. Angiotensin-mediated phosphatidylcholine hydrolysis and protein kinase C activation in mesangial cells. Am. J. Physlol. 265 (Cell Physiol. 34): C1100-C1108,1993.
3. Bendack, L. M., R. V. Sharma, and R. C. Bhalla. Altered signal transduction in vascular smooth muscle cells of spontaneously hypertensive rats. Hypertension 19, Suppl. II: III42-III48, 1992.
4. Berridge, M. J. Inositol triphosphate and diacylglycerol: two interacting second messengers. Annu. Rev. Biochem. 56::159-193, 1987.
5. Chatziantoniou, C., and W. J. Arendshorst. Angiotensin receptor sites in renal vasculature of rats developing genetic hypertension. Am. J. Physiol. 265 (Renal Fluid Electrolyte Physiol. 34): F853-F862, 1993.
6. Chatziantoniou, C., F. H. Daniels, and W. J. Arendshorst. Exaggerated renal vascular reactivity to angiotensin and thromboxane in young spontaneously hypertensive rats. Am. J. Physiol. 259 (Renal Fluid Electrolyte Physiol. 28): F372-F382, 1990.
7. Chatziantoniou, C., X. Ruan, and W. J. Arendshorst. Interactions of cAMP-mediated vasodilators with angiotensin II in rat kidney during hypertension. Am. J. Physiol. 263 (Renal Fluid Electrolyte Physiol. 32): F573-F580, 1992.
8. Chatziantoniou, C., X. Ruan, and W. J. Arendshorst. Defective G protein activation of the cAMP pathway in rat kidney during genetic hypertension. Proc. NatL Acad. Sci. USA 9: 2924-2928,1995.
9. Douglas, J. G., and U. Hopfer. Novel aspect of angiotensin receptors and signal transduction in the kidney. Annu. Rev. Physiol. 56::649-669, 1994.
10. Edwards, R. M., and N. Aiyar. Angiotensin II receptor subtypes in the kidney. J. Am. Soc. Nephrol. 3::1643-1652, 1993.
11. Fish, R. D., G. Sperti, W. S. Colucci, and D. E. Clapham. Phorbol ester increases the dihydropyridine-sensitive calcium conductance in a vascular smooth muscle cell line. Circ. Res. 62::1049-1054, 1988.
12. Griendling, K. K., T. Tsuda, B. C. Berk, and R. W.Alexander. Angiotensin II stimulation of vascular smooth muscle cells. Secondary signaling mechanisms. Am. J. Hypertens. 2::659-665, 1989.
13. Herbert, J. M., J. M. Augereau, J. Gleye, and J. P Maffrand. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 172::993-999, 1990.
14. Jackson, E. K., and W. A. Herzer. Angiotensin II/prostaglandin \2 interactions in spontaneously hypertensive rats. Hypertension Dallas 22: 688-698,1993.
15. Kobayashi, E., H. Nakano, M. Morimoto, and T. Tamaoki. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159::548-553, 1989.
16. Kost, C. K., Jr., W. A. Herzer, P. Li, and E. K. Jackson. Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 269: 82-87,1994.
17. Laher, I., L. P. Thompson, and L. Gagne. Protein kinase C as a modulator of response amplification in vascular smooth muscle. Blood Vessels 27: 333-340,1990.
18. Lassegue, B., R. W. Alexander, M. Clark, M. Akers, and K. K. Griendling. Phosphatidylcholine is a major source of phosphatidic acid and diacylglycerol in angiotensin II-stimulated vascular smooth muscle cells. Biochem. J. 292::509-517, 1993.
19. Millanvoye, E., M. Freyss-Beguin, M. Baudouin-Legros, J.-L. Paquet, P. Marche, S. Durant, and P. Meyer. Growth rate and phospholipase C activity in cardiac and aortic spontaneously hypertensive rat cells. J. Hypertens. 6, Suppl. 4: S369S371,1988.
20. Neusser, M., M. Tepel, and W. Zidek. Angiotensin II responses after protein kinase C activation in vascular smooth muscle cells of spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 21::749-753, 1993.
21. Osanai, T., and M. J. Dunn. Phospholipase C responses in cells from spontaneously hypertensive rats. Hypertension Dallas 19: 446-455,1992.
22. Pfeilschifter, J., A. Huwiler, C. Merriweather, and V. Briner. Angiotensin II stimulation of phospholipase D in rat renal mesangial cells is mediated by the AT] receptor subtype. Eur. J. Pharmacol. Mol. Pharmacol. 225::57-62, 1992.
23. Rasmussen, H., Y. Takuwa, and S. Park. Protein kinase C in the regulation of smooth muscle contraction. FASEB J. 1::177-185, 1987.
24. Resnik, T. J., T. Scott-Burdern, U. Baur, M. Burgin, and F. R. Buhler. Enhanced responsiveness to angiotensin II in vascular smooth muscle cells from spontaneously hypertensive rats is not associated with alterations in protein kinase C. Hypertension Dallas 14::293-303, 1989.
25. Ruan, X., and W. J. Arendshorst. Roles of calcium entry and mobilization signaling pathways in angiotensin II-induced renal vasoconstriction in vivo. Am. J. Physiol. 270 (Renal Fluid Electrolyte Physiol. 39): F398-F405, 1996.
26. Ruegg, U. T., and G. M. Burgess. Staurosporine, K-262 and UCN-01: potent but nonspecific inhibitors of protein kinases. Trends Pharmacol. Sci. 10::218-220, 1989.
27. Scholz, H., and A. Kurtz. Role of protein kinase C in renal vasoconstriction caused by angiotensin II. Am. J. Physiol. 259 (Cell Physiol. 28): C421-C426,1990.
28. Shibata, R., S. Morita, K. Nagai, S. Miyata, and T. Iwasaki. Effects of H-7 (protein kinase inhibitor) and phorbol ester on aortic strips from spontaneously hypertensive rats. Eur. J. Pharmacol. 175::261-271, 1990.
29. Shimamoto, Y., H. Shimamoto, C.-Y. Kwan, and E. E. Daniel. Differential effects of putative protein kinase C inhibitors on contraction of rat aortic smooth muscle. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H1300-H1306, 1993.
30. Silver, P. J., W. R. Cumiskey, and A. L. Harris. Vascular protein kinase C in Wistar-Kyoto and spontaneously hypertensive rat. Eur. J. Pharmacol. 212::143-149, 1992.
31. Takenaka, T., H. Forster, and M. Epstein. Protein kinase C and calcium channel activation as determinants of renal vasoconstriction by angiotensin II and endothelin. Circ. Res. 73::743750, 1993.
32. Tamaoki, T., H. Nomoto, I. Takahashi, Y. Kato, M. Morimoto, and F. Tomita. Staurosporine, a potent inhibitor of phospholipid/Ca2+ dependent protein kinase. Biochetn. Biophys. Res. Commun. 135::397-402, 1986.
33. Timmermans, P. B. M. W. M., P. Benefield, A. T. Chiu, W. P Herblin, P. C. Wong, and R. D. Smith. Angiotensin II receptors and functional correlates. Am. J. Hypertens. 5, Suppl.::221S-235S, 1992.
34. Uehara, Y., M. Ishii, T. Ishimitsu, and T. Sugimoto. Enhanced phospholipase C activity in vascular wall of spontaneously hypertensive rats. Hypertension Dallas 11::28-33, 1988.
35. Vyas, S. J., and E. K. Jackson. Angiotensin II: enhanced renal responsiveness in young genetically hypertensive rats. J. Pharmacol. Exp. Ther. 273::768-777, 1995.